 This study suggests that the administration of PDE-5 inhibitors, such as Tadalafil, may be beneficial in reducing renal ischemia reperfusion injury. However, further studies are needed to confirm these findings. This article was authored by Safendra Sareghar, Jhajajati Ramdam, Henry Stanza, and others.